The company was founded in July 2000, based upon the research of Dr. Theo Postmes PhD. His research and publications (e.g. in The Lancet) led to the conclusion that honey is capable of healing wounds fast and efficient.

The unique L-Mesitran products were introduced in 2002 as CE-marked products on the European market. The FDA approved the dressings in 2007 and the products are available in countries worldwide. 

Supported by published research and case studies L-Mesitran strives to be the pioneer in the honey based wound care market. Our aim is to provide high quality products for fast and efficient wound healing.

 L-Mesitran® offers a naturalbreakthrough in woundcare.